We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $9.31B
1-Year Est. Return 73.66%
This Fund
S&P 500
This Quarter Est. Return
+84.9%
1 Year Est. Return
+73.66%
3 Year Est. Return
+373.34%
5 Year Est. Return
10 Year Est. Return
AUM
$9.31B
AUM Growth
+$2.53B
Cap. Flow
+$1.27B
Cap. Flow %
13.64%
Top 10 Hldgs %
53.63%
Holding
384
New
125
Increased
85
Reduced
84
Closed
64

Top Buys

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$566M
2
SPCX
SpaceX
SPCX
+$254M
3
AMD icon
Advanced Micro Devices
AMD
+$149M
4
NOW icon
ServiceNow
NOW
+$121M
5
AVGO icon
Broadcom
AVGO
+$75.6M

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.34%
2 Technology 35%
3 Financials 5.44%
4 Industrials 4.27%
5 Healthcare 2.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSTM icon
276
Verastem
VSTM
$743M
$535K 0.01%
140,000
-223,132
-61% -$1.08M
CART icon
277
Maplebear
CART
$11.8B
$526K 0.01%
+11,103
New +$464K
VISN
278
Vistance Networks Inc
VISN
$1.48B
$511K 0.01%
40,000
-5,000
-11% -$70.6K
CNNE icon
279
Cannae Holdings
CNNE
$687M
$504K 0.01%
35,000
-35,000
-50% -$476K
GME icon
280
GameStop
GME
$8.6B
$504K 0.01%
22,817
-4,411
-16% -$101K
IACQ
281
Irenic Acquisition Corp
IACQ
$500K 0.01%
+50,000
New +$498K
MMTX
282
Miluna Acquisition Corp
MMTX
$90.1M
$488K 0.01%
+48,300
New +$486K
HTGC icon
283
Hercules Capital
HTGC
$3.3B
$474K 0.01%
30,045
+12,045
+67% +$187K
EOSE icon
284
Eos Energy Enterprises
EOSE
$1.41B
$468K 0.01%
+79,519
New +$553K
UUUU icon
285
Energy Fuels
UUUU
$3.83B
$463K 0.01%
31,900
-2,736
-8% -$50.3K
OKUR
286
OnKure Therapeutics
OKUR
$145M
$456K ﹤0.01%
100,014
+114
+0.1% +$489
HCAC
287
Hall Chadwick Acquisition Corp
HCAC
$295M
$447K ﹤0.01%
44,500
TRDA icon
288
Entrada Therapeutics
TRDA
$278M
$442K ﹤0.01%
60,000
+13,000
+28% +$125K
ALDX icon
289
Aldeyra Therapeutics
ALDX
$89.3M
$426K ﹤0.01%
+200,000
New +$344K
PLUG icon
290
Plug Power
PLUG
$3.03B
$400K ﹤0.01%
+147,700
New +$464K
IVVD icon
291
Invivyd
IVVD
$243M
$393K ﹤0.01%
+450,115
New +$564K
ITHA
292
ITHAX Acquisition Corp III
ITHA
$383K ﹤0.01%
+38,380
New +$382K
CRBP icon
293
Corbus Pharmaceuticals
CRBP
$214M
$376K ﹤0.01%
40,098
OTLK icon
294
Outlook Therapeutics
OTLK
$162M
$358K ﹤0.01%
+225,000
New +$140K
BLSH
295
Bullish
BLSH
$5.46B
$357K ﹤0.01%
+15,250
New +$530K
BLRKU
296
Bluerock Acquisition Corp Unit
BLRKU
$351K ﹤0.01%
34,800
EQ icon
297
Equillium
EQ
$140M
$349K ﹤0.01%
109,062
-153,581
-58% -$368K
MSFT icon
298
PUT
Microsoft
MSFT
$3.71T
$298K ﹤0.01%
+800
New +$324K
BACCR
299
Blue Acquisition Corp Right
BACCR
$289K ﹤0.01%
+371,119
New +$129K
KYIVW
300
Kyivstar Group Warrant
KYIVW
$288K ﹤0.01%
45,000
-30,000
-40% -$151K

Similar funds

Cantor Fitzgerald's Q2 2026 Portfolio in Review

As of Q2 2026, Cantor Fitzgerald held 384 positions worth $9.31B, up 37% from $6.78B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Cantor Fitzgerald deployed $1.27B of net new capital in Q2 2026, opening 125 new positions and adding to 85 existing holdings. Its largest new stake was SpaceX: 1,496,980 shares worth $256M.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 63% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Strategy Inc, an estimated $136M trimmed.

  • Cantor Fitzgerald's largest Q2 2026 buy was SpaceX: 1,496,980 shares worth $256M.
  • Cantor Fitzgerald added most to Marvell Technology in Q2 2026, an estimated $566M increase.
  • Cantor Fitzgerald's biggest Q2 2026 reduction was Strategy Inc, cutting an estimated $136M.
  • Cantor Fitzgerald fully exited Shell in Q2 2026, selling an estimated $39.8M.
  • Cantor Fitzgerald's ten largest holdings make up 54% of its $9.31B portfolio in Q2 2026.
  • Cantor Fitzgerald opened 125 new positions and closed 64 in Q2 2026.
  • Cantor Fitzgerald's portfolio value rose 37% quarter-over-quarter to $9.31B.

Based on Cantor Fitzgerald's 13F filing for Q2 2026, filed 14 Aug 2026.